86 related articles for article (PubMed ID: 2984082)
21. Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study.
Høgdall EV; Christensen L; Høgdall CK; Blaakaer J; Gayther S; Jacobs IJ; Christensen IJ; Kjaer SK
Oncol Rep; 2007 Nov; 18(5):1051-9. PubMed ID: 17914554
[TBL] [Abstract][Full Text] [Related]
22. [Morphologic studies of endometrial cancer for biological assessment of nuclear grading].
Köhler U
Zentralbl Gynakol; 1991; 113(18):995-1003. PubMed ID: 1750299
[TBL] [Abstract][Full Text] [Related]
23. Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study.
Chan JK; Tian C; Monk BJ; Herzog T; Kapp DS; Bell J; Young RC;
Cancer; 2008 May; 112(10):2202-10. PubMed ID: 18348296
[TBL] [Abstract][Full Text] [Related]
24. Histologic correlates of progression-free interval and survival in ovarian clear cell adenocarcinoma.
Kennedy AW; Biscotti CV; Hart WR; Tuason LJ
Gynecol Oncol; 1993 Sep; 50(3):334-8. PubMed ID: 8406197
[TBL] [Abstract][Full Text] [Related]
25. [Prognostic factors in ovarian carcinoma].
Sliutz G
Wien Med Wochenschr; 1996; 146(1-2):14-7. PubMed ID: 8835490
[TBL] [Abstract][Full Text] [Related]
26. The pathological assessment of ovarian neoplasms. III: The malignant "epithelial" tumours.
Russell P
Pathology; 1979 Jul; 11(3):493-532. PubMed ID: 230444
[TBL] [Abstract][Full Text] [Related]
27. Validation of the histologic grading for ovarian clear cell adenocarcinoma: a retrospective multi-institutional study by the Japan Clear Cell Carcinoma Study Group.
Yamamoto S; Kasajima A; Takano M; Yaegashi N; Fujiwara H; Kuzuya K; Kigawa J; Tsuda H; Kurachi H; Kikuchi Y; Sugiyama T; Tsuda H; Moriya T
Int J Gynecol Pathol; 2011 Mar; 30(2):129-38. PubMed ID: 21293288
[TBL] [Abstract][Full Text] [Related]
28. Unraveling the two entities of endometrioid ovarian cancer: a single center clinical experience.
Mangili G; Bergamini A; Taccagni G; Gentile C; Panina P; Viganò P; Candiani M
Gynecol Oncol; 2012 Sep; 126(3):403-7. PubMed ID: 22609111
[TBL] [Abstract][Full Text] [Related]
29. Endometriosis does not confer improved prognosis in ovarian carcinoma of uniform cell type.
Cuff J; Longacre TA
Am J Surg Pathol; 2012 May; 36(5):688-95. PubMed ID: 22498820
[TBL] [Abstract][Full Text] [Related]
30. [Endometrioid carcinoma of the ovary: characteristics of form and prognostic significance of the neoplasm].
Zampi G; Colafranceschi M; Fornari B
Arch De Vecchi Anat Patol; 1974 Dec; 60(2):263-83. PubMed ID: 4620209
[No Abstract] [Full Text] [Related]
31. Changes in the histocytological grading of epithelial ovarian carcinoma following treatment.
Dauplat J; Nieberg RK; Philippe A; Hacker NF
Int J Gynecol Pathol; 1988; 7(1):12-22. PubMed ID: 2832335
[TBL] [Abstract][Full Text] [Related]
32. Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis.
McCluggage WG
Pathology; 2011 Aug; 43(5):420-32. PubMed ID: 21716157
[TBL] [Abstract][Full Text] [Related]
33. [Evaluation of prognostic parameters in colorectal carcinoma. I. Histopathological variability].
Lanza G; Borghi L; Ballotta MR; Ferretti S; Morsiani E; Buccoliero F; Navarra G; Piva E; Facchini L; Cavazzini L
Pathologica; 1992; 84(1090):131-53. PubMed ID: 1331943
[TBL] [Abstract][Full Text] [Related]
34. CA 125 and carcinoembryonic antigen levels in cyst fluid, ascites and serum of patients with ovarian neoplasms.
Harłozińska A; Bar JK; Gawlikowski W; Richter R; Cisło M
Ann Chir Gynaecol; 1991; 80(4):368-75. PubMed ID: 1667567
[TBL] [Abstract][Full Text] [Related]
35. [The degree of differentiation and the clinical course of ovarian cancer].
Vinokurov VL; Iurkova LE; Zagol'skaia VN
Vopr Onkol; 1985; 31(3):55-63. PubMed ID: 2986351
[TBL] [Abstract][Full Text] [Related]
36. Histological grading of epithelial ovarian carcinomas.
Doyle EM; Foley M; Kelehan P; Mooney EE
J Obstet Gynaecol; 2007 Jan; 27(1):71-4. PubMed ID: 17365464
[TBL] [Abstract][Full Text] [Related]
37. Prognostic variables in epithelial ovarian cancer: a review.
Friedlander ML
Aust N Z J Obstet Gynaecol; 1984 Nov; 24(4):256-61. PubMed ID: 6100044
[No Abstract] [Full Text] [Related]
38. Biopsy examination of squamous cell carcinoma of the tongue: source of significant prognostic information?
Moor JW; Wills S; Holzle F; Ong TK; Mitchell DA; MacLennan KA; Kanatas AN
Br J Oral Maxillofac Surg; 2010 Dec; 48(8):594-7. PubMed ID: 20045230
[TBL] [Abstract][Full Text] [Related]
39. Quantitative prognostic features in FIGO I ovarian cancer patients without postoperative treatment.
Brugghe J; Baak JP; Wiltshaw E; Brinkhuis M; Meijer GA; Fisher C
Gynecol Oncol; 1998 Jan; 68(1):47-53. PubMed ID: 9454660
[TBL] [Abstract][Full Text] [Related]
40. Grading of endometrial carcinoma.
Kurman RJ
Verh Dtsch Ges Pathol; 1991; 75():376-7. PubMed ID: 1724845
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
